GE Healthcare IPO this year ‘looks unlikely’ after Danaher deal, CEO Culp says – CNBC

  1. GE Healthcare IPO this year ‘looks unlikely’ after Danaher deal, CEO Culp says CNBC
  2. GE to sell BioPharma business to Danaher for $21.4B Fox Business
  3. GE to Sell Its Biotech Business to Danaher for $21 Billion The Wall Street Journal
  4. GE shares surge 13% after Danaher agrees to buy biopharma business for $21.4 billion CNBC
  5. GE’s stock soars after deal to sell biopharma business to Danaher for $21.4 billion MarketWatch
  6. View full coverage on Google News

…read more

Source:: Tech News By Google News

Leave a Comment